Thread-embedding Combined With Auricular Acupuncture for Non-specific Chronic Low Back Pain
- Conditions
- Chronic Non-Specific Low Back Pain
- Registration Number
- NCT06682273
- Lead Sponsor
- University of Medicine and Pharmacy at Ho Chi Minh City
- Brief Summary
Low back pain (LBP) is a significant global health issue, with cases expected to rise by 36.4% by 2050. Chronic LBP (cLBP), lasting over three months, is mostly non-specific cLBP (cNLBP), posing a challenge for effective management. Common treatments include medication, exercise, and acupuncture.
This study explores the combined use of thread-embedding and auricular acupuncture for treating cNLBP, as combining these methods is thought to enhance effectiveness. Participants with cNLBP will be randomized into four groups to receive either the combination of both treatments, each treatment individually with a sham, or both shams. The study will last eight weeks, with four weeks of intervention and four weeks of follow-up. Treatment outcomes, including pain, disability, medication use, and quality of life, will be evaluated, along with monitoring for adverse effects.
- Detailed Description
Low back pain (LBP) is a major public health issue worldwide. In 2020, there were over half a billion cases of LBP globally, and by 2050, the total number of LBP cases is expected to increase by 36.4% worldwide. LBP accounts for 7.7% of total Years Lived with Disability, making it the largest contributor to the global disability burden.
When lasting three months or more, LBP is classified as chronic (cLBP). Most cLBP is non-specific cLBP (cNLBP). Managing cNLBP remains challenging. Recommended therapies include short-term medication, manipulation, supervised exercise, cognitive behavioral therapy, and multidisciplinary treatment. According to the Clinical Practice Guideline from the American College of Physicians, clinicians and patients should initially consider non-pharmacologic treatments, including acupuncture as one of the options.
There is evidence regarding the effectiveness of thread-embedding acupuncture (TEA) and auricular acupuncture (AA) in the treatment of cNLBP. TEA uses the principle of selecting points on the body, while AA involves selecting points on the ear. The difference in the point selection principles of these two methods has led clinicians to often combine them in hopes of enhancing treatment efficacy. However, evidence on the effectiveness of combining these two methods in treating cNLBP remains lacking. This study aims to clarify whether the combination of these methods is more effective than using them individually.
Eligible participants with cNLBP, defined as LBP lasting more than three months without any reasonable explanation and determined by a physician to be nonspecific, will be enrolled and subsequently randomized into four groups: receiving the combination of TEA and AA (TEA + AA group), receiving TEA and sham AA (TEA + sham AA group), receiving AA and sham TEA (AA + sham TEA group), and receiving sham TEA and sham AA (Sham both group), with a 1:1:1:1 allocation ratio.
The study will last for eight weeks, with four weeks of intervention and four weeks of follow-up. AA and sham AA will be administered weekly during the four-week intervention (four sessions). TEA and sham TEA will be administered every two weeks during the four-week intervention (two sessions). Data on treatment efficacy will include disability index, pain score, amount of analgesic medication needed, quality of life score, and global improvement. Additionally, adverse effects will be monitored and recorded.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 168
- Patients with low back pain at the outpatient clinic.
- Diagnosed with non-specific low back pain persisting for more than 3 months, without radiation to the legs.
- Pain-NRS score ā„ 4 on a 10-point scale.
- Independent ambulation capability (with or without walking aids).
- Consent to participate in the study.
- History of prior lumbar spine surgery.
- Known or suspected severe spinal conditions (e.g., cancer, vertebral fracture, spinal infection, or cauda equina syndrome).
- Signs of concurrent involvement of lumbar nerve roots, plexus, sciatic nerve, other leg nerves, or diagnosed polyneuropathy confirmed by electrodiagnosis.
- Presence of systemic inflammatory diseases, including rheumatoid arthritis, gout, ankylosing spondylitis, or psoriatic arthritis.
- Unstable or untreated severe health conditions (such as end-stage renal disease, advanced liver failure, NYHA class IV heart failure).
- Alcohol abuse or substance dependence.
- Use of anti-inflammatory medication within 2 weeks prior to enrollment.
- Acupuncture treatment within the past 4 weeks.
- Previous treatment with thread-embedding or auricular acupuncture for any condition.
- Damaged skin in the acupuncture area or history of hypersensitivity reactions to acupuncture.
- Pregnancy or breastfeeding.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Change in Oswestry Disability Index (ODI) percentage score Week 0, Week 2, Week 4, Week 6, and Week 8 The Oswestry Disability Index (ODI) percentage score evaluates the impact of low back pain on various activities (sleeping, self-care, sex life, social life, and traveling) using six rating options (0 to 5). Participants select the most appropriate response, and the total score is calculated as a percentage of the maximum possible score (50 if all sections are completed). A score of zero indicates no disability, while a score of 100% implies significant disability.
- Secondary Outcome Measures
Name Time Method Change in pain score on the Numeric Rating Scale (NRS) Week 0, Week 2, Week 4, Week 6, and Week 8 The pain score on the Numeric Rating Scale (NRS) is a subjective measure used to assess the intensity of pain experienced by an individual. Participants are asked to rate their pain on a scale from 0 to 10, where 0 represents no pain and 10 indicates the worst possible pain.
Change in the number of paracetamol tablets used Week 2, Week 4, Week 6, and Week 8 The number of paracetamol 500mg tablets used per week will be recorded.
Change in the Patient-Reported Outcomes Measurement Information System Global Health 10 (PROMIS-GH-10) score Week 0, Week 2, Week 4, Week 6, and Week 8 The Patient-Reported Outcomes Measurement Information System Global Health 10 (PROMIS-GH-10) is a 10-item assessment tool that includes ratings for four general items (health, quality of life, physical health, and mental health) and six additional items covering five health domains: physical function (1 item), fatigue (1 item), pain (1 item), emotional distress (1 item), and social health (2 items). Each question has five response options ranging from 1 to 5, except for the pain scale, which ranges from 0 to 10. The total score ranges from 9 to 55, with higher scores indicating better quality of life.
Global improvement rate Week 2, Week 4, Week 6, and Week 8 Global improvement is assessed through the patients global impression of change, using a 7-point scale: 1 = completely recovered, 2 = greatly improved, 3 = somewhat improved, 4 = no change, 5 = somewhat worse, 6 = significantly worse, and 7 = extremely worsened. Participants who score 1 or 2 are considered improved, those with scores of 3 to 5 are classified as unchanged, and scores of 6 or 7 indicate deterioration.
Proportion of intervention-related adverse events Up to eight weeks For thread-embedding acupuncture and sham thread-embedding acupuncture, anticipated adverse events include local discomfort, an increase in body temperature following treatment, local hematoma or subcutaneous bleeding, local swelling, induration, pain, redness, infection, abscess, itching, and anaphylaxis. Anticipated adverse events for auricular acupuncture and sham auricular acupuncture include pain at the insertion site, local discomfort, skin irritation (itching and redness), local inflammation and bleeding, chondritis, dizziness, nausea, and hypersensitivity reactions. Additionally, any unforeseen adverse events related to these procedures are documented and monitored.
Trial Locations
- Locations (1)
Nhan Dan Gia Dinh Hospital
š»š³Ho Chi Minh City, Vietnam